References
- Amin, R P, Hamadeh, H K, Bushel, P R, Bennett, L, Afshari, C A, Paules, R S. Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology 2002; 181–182:555–563.
- Hammerman, M R. Potential role of growth factors in the prophylaxis and treatment of acute renal failure. Kidney Inter, Suppl 1998; 64:S19–S22.
- Hammerman, M R. Growth factors and apoptosis in acute renal injury. Curr Opin Nephrol Hypertens 1998; 7:419–424., [PUBMED], [INFOTRIEVE], [CSA]
- Huang, Q, Dunn, R T, Jayadev, S, DiSorbo, O, Pack, F D, Farr, S B, Raymond, E, Stoll, R E, Blanchard, K T. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 2001; 63:196–207., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ichimura, T, Bonventre, J V, Bailly, V, Wei, H, Hession, C A, Cate, R L, Sanicola, M. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998; 273:4135–4142., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yoshida, T, Kurella, M, Beato, F, Min, H, Ingelfinger, J R, Stears, R L, Swinford, R D, Gullans, S R, Tang, S S. Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. Kidney Int 2002; 61:1646–1654., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chin, K V, Kong, A NT. Application of DNA microarrays in pharmacogenomics and toxicogenomics. Pharm Res 2002; 19:1773–1778., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kriete, A, Anderson, M K, Love, B. Combined histomorphomeric and gene-expression profiling applied to toxicology. Genome Biol 2003; 4:R32., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pennie, W, Pettit, S D, Lord, P G. Toxicogenomics in risk assessment: an overview of an HESI collaborative research program. Environ Health Perspect 2004; 112:417–419., [PUBMED], [INFOTRIEVE], [CSA]
- Lesko, L J, Woodcock, J. Pharmacogenomic-guided drug development: regulatory perspective. Pharmacogenomics J 2002; 2:20–24., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Philips, K A, Veestra, D L, Oren, E, Lee, J K, Sadee, W. Potential role of pharmacogenomics in reducing adverse drug reactions—a systematic review. JAMA 2001; 286:2270–2279., [CROSSREF]
- Mah, J TL, Wong, J YY, Lee, E JD. Pharmacogenetics: role in modifying drug dosage regimens. Ann Acad Med Singap 2000; 29:628–632., [PUBMED], [INFOTRIEVE], [CSA]
- Meyer, U A. Pharmacogentics and adverse drug reactions. Lancet 2000; 356:1667–1671., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Meyer, U A, Gut, J. Genomics and the prediction of xenobiotic toxicity. Toxicology 2002; 181–182:463–466., [CROSSREF]
- Chang, J C, Wooten, E C, Tsimelzon, A, Hilsenbeck, S G, Gutierrez, C, Elledge, R, Mohsin, S, Osborne, C K, Chamness, G C, Allred, D C, O'Connell, P. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003; 362:362–369., [PUBMED], [INFOTRIEVE], [CROSSREF]
- ILSI Health and Environmental Sciences Institute, International Life Sciences Institute. Technical committee on application of genomics to mechanism-based risk assessment: statue, findings and next steps March 2003 [on line]. , Available from URL: http://hesi.ilsi.org/file/ACF5D34.pdf [Assessed 2004 Feb. 19].
- Ulrich, R G, Rockett, J C, Gibson, G G, Pettit, S D. Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression. Environ Health Perspect 2004; 112:423–427., [PUBMED], [INFOTRIEVE], [CSA]
- Baker, V A, Harries, H M, Waring, J F, Duggan, C M, Ni, H A, Jolly, R A, Yoon, L W, De Souza, A T, Schmid, J E, Brown, R H, Ulrich, R G, Rockett, J C. Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays. Environ Health Perspect 2004; 112:428–438., [PUBMED], [INFOTRIEVE], [CSA]
- Waring, J F, Ulrich, R G, Flint, N, Morfitt, D, Kalkuhl, A, Staedtler, F, Lawton, M, Beekman, J M, Suter, L. Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene. Environ Health Perspect 2004; 112:439–448., [PUBMED], [INFOTRIEVE], [CSA]
- Waring, J F, Ciurlionis, R, Jolly, R A. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 2001; 120:359–368., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Newton, R K, Aardema, M, Aubrecht, J. The utility of DNA microarrays for characterizing genotoxicity. Environ Health Perspect 2004; 112:420–422., [PUBMED], [INFOTRIEVE], [CSA]
- Thompson, K L, Afshari, C A, Amin, R P, Bertram, T A, Car, B, Cunningham, M, Kind, C, Kramer, J A, Lawton, M, Mirsky, M, Naciff, J M, Oreffo, V, Pine, P S, Sistare, F D. Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. Environ Health Perspect 2004; 112:488–494., [PUBMED], [INFOTRIEVE], [CSA]
- Kramer, J A, Pettit, S D, Amin, R P, Bertram, T A, Car, B, Cunningham, M, Curtiss, S W, Davis, J W, Kind, C, Lawton, M, Naciff, J M, Oreffo, V, Roman, R J, Sistare, F D, Stevens, J, Thompson, K, Vickers, A E, Wild, S, Afshari, C A. Overview of the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ Health Perspect 2004; 112:460–464., [PUBMED], [INFOTRIEVE], [CSA]
- Amin, R P, Vickers, A E, Sistare, F, Thompson, K L, Roman, R J, Lawton, M, Kramer, J, Hamadeh, H K, Collins, J, Grissom, S, Bennett, L, Tucker, J, Wild, S, Kind, C, Oreffo, V, Davis, J W II, Curtiss, S W, Naciff, J M, Cunningham, M, Tennant, R, Stevens, J, Car, B, Bertram, T A, Afshari, C A. Identification of putative gene-based markers of renal toxicity. Environ Health Perspect 2004; 112:465–479., [PUBMED], [INFOTRIEVE], [CSA]
- ILSI-HESI Genomics Subcommittee Update: Nephrotoxicity Working Group June 5 2003 [on line]. , Available from URL: http://www.ilsi.org/committees/hesi/genomics/Afshari-Nephrotox.pdf. [Assessed 2004 Feb. 19]
- Selkirk, J K, Tennant, R W. The NIEHS National Toxicognomics Program [abstract] Society for Risk Analysis 2002 Annual Meeting [on line]. , Available from URL: http://www.riskworld.com/Abstract/2002/SRAam02/ab02aa260.htm [Assessed 2004 Feb. 19].
- Cunningham, M L, Irwin, R, Boorman, G. Tox/Path team takes on differential gene expression. Environ Health Perspect 2003; 111:A814–A815., [PUBMED], [INFOTRIEVE], [CSA]
- Boorman, G A, Haseman, J K, Waters, M D, Hardisty, J F, Sills, R C. Quality review procedures necessary for rodent pathology databases and toxicogenomic studies: the National Toxicology Program experience. Toxicol Pathol 2002; 30:88–92., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mendrick, D L. Toxicogenomic Predictive Modeling [presentation] National Research Council Committee on Emerging Issues and Data on Environmental Contaminants Second Meeting: February 6–7, 2003 [on line]., Available from URL: http://dels.nas.edu/emergingissues/docs/Mendrick.pdf [Assessed 2004 Feb. 19].
- Mansfield, T, Vincent, M R. CuraGen Corporation: company profile. Pharmacogenomics 2002; 3:551–554, [on line]. Available from URL: http://www.pharmacogenomics.co.uk/admin/articlefile/PGS030413.pdf [Assessed 2004 Feb. 19]. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Toxicogenomics-Predictive Toxicogenomic Screen. CuraGen Corporation [on line]. , Available from URL: http://www.curagen.com/rnd/pts.asp [Assessed 2004 Feb. 19].
- FDA Draft Guidance for Industry: Pharmacogenomic Data Submissions Nov. 2003 [on line]. , Available from URL: http://www.fda.gov/cber/gdlns/pharmdtasub.pdf. [Assessed 2004 Feb. 19].
- EMEA CHMP Position Paper on Terminology in Pharmacogenetics. Adopted Nov. 2002 [on line]. , Available from URL: http://www.emea.eu.int/pdfs/human/press/pp/307001en.pdf [Assessed 2004 Feb. 19].